Navigation Links
MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology
Date:10/23/2008

GAITHERSBURG, Md., Oct. 23 /PRNewswire/ -- MedImmune today announced that researchers will present eight posters from its inflammatory disease program at the Annual Meeting of the American College of Rheumatology, from October 24 to 29, 2008 at the Moscone Center in San Francisco, California.

"MedImmune is working on a number of potential solutions for patients struggling with systemic autoimmune rheumatic diseases," said Barbara White, M.D., vice president, clinical development, respiratory, inflammation, and autoimmunity. "We are pleased to share promising basic research and translational science data relevant to the development of new treatments for diseases such as lupus, rheumatoid arthritis, and myositis"

MedImmune programs that will be discussed include:

-- MEDI-545 - MEDI-545 is a monoclonal antibody (MAb) targeting

interferon-alpha, which regulates processes involved in autoimmune

diseases. MedImmune has launched a broad development program with this

molecule to assess its potential to treat or prevent a variety of

immunological disorders. Currently, MedImmune is conducting a phase 2a

trial in patients with systemic lupus erythematosus (SLE) and a phase 1b

study in patients with active dermatomyositis and polymyositis. The

company has also conducted clinical trials in psoriasis with MEDI-545.

-- CAM-3001 - CAM-3001 is a MAb with potential to help patients with

rheumatoid arthritis. The antibody targets the alpha sub-unit of the

granulocyte-macrophage colony stimulating factor receptor (GM-CSFR).

CAM-3001 is a phase 1 clinical stage program.

-- ICOS - ICOS (Inducible costimulator) is a receptor on activated T-cells

that plays a central role in humoral immunity. Elevated levels of ICOS

are present in patients with autoimmune diseases and effector cytokines

have been shown to corr
'/>"/>

SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production
2. MedImmune Expands R&D Capacity with New Research Facility in Cambridge, U.K.
3. MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease
4. Pinnacle Biologics Announces Stock Purchase Agreement With MedImmune
5. MedImmunes Brian Rosen Honored by Montgomery County Chamber at 49th Annual Awards Dinner
6. Depth of MedImmunes Respiratory Disease Research Program Highlighted at Annual Meeting of the American Thoracic Society
7. MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
8. MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research
9. Seneca Valley High School Student Receives Science Award From MedImmune
10. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
11. MedImmune Submits Biologics License Application to FDA for Motavizumab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2010)... Feb. 8 /PRNewswire-FirstCall/ - YM BioSciences Inc. ... and financial results for the second quarter of ... ,, "After rigorous evaluation of numerous global in-licensing ... clinical-stage, Melbourne -based drug development company, into ... Allan , Chairman & CEO of YM BioSciences ...
(Date:2/8/2010)... biosensor surface for label-free biomolecular interaction analysis now offers ... proteins, Protein A and Protein G for coupling antibodies. ... ... Diego, CA (PRWEB) February 8, 2010 -- Silicon Kinetics ... introduced the world,s first 3D biosensor surface for label-free ...
(Date:2/8/2010)... Biocell Center announced today its ... attending the Society for Maternal-Fetal Medicine,s (SMFM) annual ... perinatologists and Ob/Gyn doctors worldwide for several years," ... Center Corporation. "We understand the effects that high-risk ... we are hoping to inform women undergoing amniocentesis ...
(Date:2/8/2010)... of schedule ,, TSX Exchange Symbol: RVX ,, CALGARY, ... or the "Company") (TSX:RVX) announced today the completion of ... its lead drug RVX-208. "The completion of enrollment for ... ahead of our original schedule, is a very exciting ... Cleveland Clinic. At this rate we could be seeing ...
Breaking Biology Technology:YM BioSciences reports second quarter 2010 operational and financial results 2YM BioSciences reports second quarter 2010 operational and financial results 3YM BioSciences reports second quarter 2010 operational and financial results 4YM BioSciences reports second quarter 2010 operational and financial results 5YM BioSciences reports second quarter 2010 operational and financial results 6YM BioSciences reports second quarter 2010 operational and financial results 7YM BioSciences reports second quarter 2010 operational and financial results 8YM BioSciences reports second quarter 2010 operational and financial results 9YM BioSciences reports second quarter 2010 operational and financial results 10YM BioSciences reports second quarter 2010 operational and financial results 11YM BioSciences reports second quarter 2010 operational and financial results 12Silicon Kinetics Announces New Biosensor Chips With Wide Palette of Surface Chemistries 2Biocell Center Furthers Its Commitment to Maternal-Fetal Medicine 2Resverlogix Completes Patient Recruitment for ASSERT Trial 2Resverlogix Completes Patient Recruitment for ASSERT Trial 3Resverlogix Completes Patient Recruitment for ASSERT Trial 4
... Insect, Plant, Bacteria, and Yeast Cells , ... , New Brunswick Scientific Co. ... 1-800-631-5417 or 1-732-287-1200; bioinfo@nbsc.com, www.nbsc.com/bi5.htm ... bottles have,become the lab standard in most fermentation and cell,culture research labs, lack of ...
... , ... , This Application ... in a BioFlo ,110 benchtop fermentor/bioreactor system. The,modular BioFlo 110 ... to,enable growth of a wide variety of cultures, including,mammalian, insect, plant, ...
... , Joseph Fox 1 , Joanne ... 1 Shimadzu Scientifi c Inc., Columbia, ... , Introduction ... spot (i.e. no separation) acquisitions for the analysis of complex peptide mixtures. These ...
Other Biology Technology:An Easy-to-Use Research Fermentor/Bioreactor 2An Easy-to-Use Research Fermentor/Bioreactor 3CHO Cell Culture Application Using a BioFlo 110 Benchtop Bioreactor 2CHO Cell Culture Application Using a BioFlo 110 Benchtop Bioreactor 3CHO Cell Culture Application Using a BioFlo 110 Benchtop Bioreactor 4LC-MALDI and MALDI-MS/MS for the Analysis of Complex Peptide Mixtures 2LC-MALDI and MALDI-MS/MS for the Analysis of Complex Peptide Mixtures 3LC-MALDI and MALDI-MS/MS for the Analysis of Complex Peptide Mixtures 4
(Date:2/9/2010)... 9 Fujitsu Frontech North ... computer products including peripherals, biometric security solutions and ... new Fairmont Pacific Rim hotel in ... the new Fujitsu WT-A511 UHF-Band RFID (Radio Frequency ... of 10,000 employee uniforms and 25,000 bathrobes, towels, ...
(Date:2/8/2010)... Around 30 to 40 million years ago, grasses ... capitalized on falling levels of atmospheric carbon dioxide by ... supply that, like a fuel-injection system in a car, ... , The rise of C4 grasses is not disputed. ... up to 20 percent of our planet,s vegetational covering. ...
(Date:2/8/2010)... common disorder of the senses. Tragically, it commonly strikes ... to learn speech and language. In many cases, ... over a long period of months to years, but ... happens, making prospects for prevention and cure very slim. ... to be due to defects in just one gene ...
Breaking Biology News(10 mins):New Fujitsu UHF RFID Technology Implemented at Fairmont Pacific Rim Hotel for Advanced Inventory Monitoring 2New Fujitsu UHF RFID Technology Implemented at Fairmont Pacific Rim Hotel for Advanced Inventory Monitoring 3New Fujitsu UHF RFID Technology Implemented at Fairmont Pacific Rim Hotel for Advanced Inventory Monitoring 4New Fujitsu UHF RFID Technology Implemented at Fairmont Pacific Rim Hotel for Advanced Inventory Monitoring 5Brown biologist solves mystery of tropical grasses' origin 2Brown biologist solves mystery of tropical grasses' origin 3Mice shed new light on causes of childhood deafness 2Explosive Growth Fuels Expansion of ADVOCATE 26apos 3Bs Management Team 65042 1Explosive Growth Fuels Expansion of ADVOCATE 26apos 3Bs Management Team 65042 2Explosive Growth Fuels Expansion of ADVOCATE 26apos 3Bs Management Team 65042 3Brain Abnormalities in Parkinson 26apos 3Bs Patients Develop Before Symptoms Occur According to Feinstein Scientists 65037 1Brain Abnormalities in Parkinson 26apos 3Bs Patients Develop Before Symptoms Occur According to Feinstein Scientists 65037 2Brain Abnormalities in Parkinson 26apos 3Bs Patients Develop Before Symptoms Occur According to Feinstein Scientists 65037 3Healthcare Trust of America Inc Executes Agreement to Acquire 80 562 Square Foot Medical Office Portfolio Located in Atlanta Georgia 65032 1Healthcare Trust of America Inc Executes Agreement to Acquire 80 562 Square Foot Medical Office Portfolio Located in Atlanta Georgia 65032 2Healthcare Trust of America Inc Executes Agreement to Acquire 80 562 Square Foot Medical Office Portfolio Located in Atlanta Georgia 65032 3
... new molecule that inhibits proliferation of a broad range ... vivo. The findings, published in the May issue of ... members are most likely to play a role in ... small molecule kinase inhibitors must display a broad reactivity ...
... found that people with long-standing, severe paralysis can generate signals ... and these signals can be detected, recorded, routed out of ... enabling a paralyzed patient to perform basic tasks. , ... present the first published results from the initial participants in ...
... compound that dramatically decreases the damage to neurons in rats ... the Week" in the May 26 issue of the Journal ... Biology journal. , Stroke is the third leading cause of ... of adult disability. An ischemic stroke occurs when a cerebral ...
Other Biology News:Unique dual target specificity of kinase inhibitor key for success against cancer 2Brain-computer link lets paralyzed patients convert thoughts into actions 2Brain-computer link lets paralyzed patients convert thoughts into actions 3Brain-computer link lets paralyzed patients convert thoughts into actions 4Brain-computer link lets paralyzed patients convert thoughts into actions 5New compound reduces stroke damage 2
... first time, you can identify and characterize ... without interferences. The Agilent Multiple Affinity Removal ... high-abundant proteins from human serum, plasma, CSF ... device. With this revolutionary system, you can: ...
... Tissue Arrays are intended for laboratory research ... fixed in neutral buffered formalin and embedded ... was performed by certified pathologists. Tissue ... and relocated into a new recipient paraffin ...
... Two-Color RNA Spike-In Kit contains in vitro ... to complementary control probes on Agilents microarrays, ... serve as a positive microarray control in ... This kit is a required component of ...
... GenePix Pro is the industry standard microarray ... combination of imaging and analysis tools, visualizations, ... GenePix Pro is included with every GenePix ... from third-party scanners and all types of ...
Biology Products: